Intron 4-5 hTERT DNA Hypermethylation in Merkel Cell Carcinoma: Frequency, Association with Other Clinico-pathological Features and Prognostic Relevance
- PMID: 33909215
- PMCID: PMC8370894
- DOI: 10.1007/s12022-021-09669-y
Intron 4-5 hTERT DNA Hypermethylation in Merkel Cell Carcinoma: Frequency, Association with Other Clinico-pathological Features and Prognostic Relevance
Abstract
Merkel cell carcinoma (MCC) is an aggressive skin tumor with neuroendocrine differentiation, mainly affecting elderly population or immunocompromised individuals. As methylation of the human telomerase reverse transcriptase (mhTERT) has been shown to be a prognostic factor in different tumors, we investigated its role in MCC, in particular in intron 4-5 where rs10069690 has been mapped and recognized as a cancer susceptibility locus. DNA methylation analysis of hTERT gene was assessed retrospectively in a cohort of 69 MCC patients from the University of Bologna, University of Turin and University of Insubria. Overall mortality was evaluated with Kaplan-Meier curves and multivariable Royston-Parmar models. High levels of mhTERT (mhTERThigh) (HR = 2.500, p = 0.015) and p63 (HR = 2.659, p = 0.016) were the only two clinico-pathological features significantly associated with a higher overall mortality at the multivariate analysis. We did not find different levels of mhTERT between MCPyV (+) and (-) cases (21 vs 14, p = 0.554); furthermore, mhTERThigh was strongly associated with older age (80.5 vs 72 years, p = 0.026), no angioinvasion (40.7% vs 71.0%, p = 0.015), lower Ki67 (50 vs 70%, p = 0.005), and PD-L1 expressions in both tumor (0 vs 3%, p = 0.021) and immune cells (0 vs 10%, p = 0.002). mhTERT is a frequently involved epigenetic mechanism and a relevant prognostic factor in MCC. In addition, it belongs to the shared oncogenic pathways of MCC (MCPyV and UV-radiations) and it could be crucial, together with other epigenetic and genetic mechanisms as gene amplification, in determining the final levels of hTERT mRNA and telomerase activity in these patients.
Keywords: HTERT; HTERT intron 4–5; Merkel cell carcinoma; Merkel cell polyomavirus; Methylation; Rs10069690; Telomerase.
© 2021. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures



Similar articles
-
PD-1 (PDCD1) promoter methylation in Merkel cell carcinoma: prognostic relevance and relationship with clinico-pathological parameters.Mod Pathol. 2019 Sep;32(9):1359-1372. doi: 10.1038/s41379-019-0261-5. Epub 2019 Apr 11. Mod Pathol. 2019. PMID: 30976104
-
Lower expression of CADM1 and higher expression of MAL in Merkel cell carcinomas are associated with Merkel cell polyomavirus infection and better prognosis.Hum Pathol. 2016 Feb;48:1-8. doi: 10.1016/j.humpath.2015.09.030. Epub 2015 Oct 23. Hum Pathol. 2016. PMID: 26772392
-
Expression of the IDO1/TDO2-AhR pathway in tumor cells or the tumor microenvironment is associated with Merkel cell polyomavirus status and prognosis in Merkel cell carcinoma.Hum Pathol. 2019 Feb;84:52-61. doi: 10.1016/j.humpath.2018.09.003. Epub 2018 Sep 18. Hum Pathol. 2019. PMID: 30240768
-
Merkel cell carcinoma - recent advances in the biology, diagnostics and treatment.Int J Biochem Cell Biol. 2014 Aug;53:536-46. doi: 10.1016/j.biocel.2014.04.023. Epub 2014 May 5. Int J Biochem Cell Biol. 2014. PMID: 24811434 Review.
-
Molecular pathogenesis of Merkel cell carcinoma.Exp Dermatol. 2009 Mar;18(3):193-8. doi: 10.1111/j.1600-0625.2009.00853.x. Exp Dermatol. 2009. PMID: 19400830 Review.
Cited by
-
Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms.Head Neck Pathol. 2022 Mar;16(1):123-142. doi: 10.1007/s12105-022-01435-8. Epub 2022 Mar 21. Head Neck Pathol. 2022. PMID: 35312985 Free PMC article. Review.
-
Role of Virus-Induced Host Cell Epigenetic Changes in Cancer.Int J Mol Sci. 2021 Aug 3;22(15):8346. doi: 10.3390/ijms22158346. Int J Mol Sci. 2021. PMID: 34361112 Free PMC article. Review.
-
Clinical-Pathological Evaluation and Prognostic Analysis of 228 Merkel Cell Carcinomas Focusing on Tumor-Infiltrating Lymphocytes, MCPYV Infection and ALK Expression.Endocr Pathol. 2022 Jun;33(2):289-303. doi: 10.1007/s12022-022-09716-2. Epub 2022 May 12. Endocr Pathol. 2022. PMID: 35551625 Free PMC article.
-
The Prognostic Value of Proliferative Activity in Cutaneous Melanoma: A Pilot Study Evaluating the Mitotic Rate and Ki67 Index to Predict Patient Outcomes.Biomedicines. 2024 Jun 13;12(6):1318. doi: 10.3390/biomedicines12061318. Biomedicines. 2024. PMID: 38927524 Free PMC article.
-
Understanding Merkel Cell Carcinoma: Pathogenic Signaling, Extracellular Matrix Dynamics, and Novel Treatment Approaches.Cancers (Basel). 2025 Apr 2;17(7):1212. doi: 10.3390/cancers17071212. Cancers (Basel). 2025. PMID: 40227764 Free PMC article. Review.
References
-
- Busam KJ, Walsh N, Woods BA. Merkel cell carcinoma. In: Elder DE, Massi D, Scolyer RA, Willemze R, editors. World Health Organization classification of skin tumors. 4. Lyon: IARC Press; 2018. pp. 48–50.
-
- Amin MB, Edge SB, Greene FL, et al. AJCC cancer staging manual. 8. New York: Springer; 2017.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials